Inhaled ICI 204,219 Blocks Antigen-Induced Bronchoconstriction in Subjects With Bronchial Asthma
- 1 February 1994
- Vol. 105 (2) , 483-488
- https://doi.org/10.1378/chest.105.2.483
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthmaJournal of Allergy and Clinical Immunology, 1992
- Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsThe Lancet, 1991
- 465 Inhibition by aerosolized ICI 204,219, LTD4 receptor antagonist, of allergen-induced bronchoconstrictionJournal of Allergy and Clinical Immunology, 1991
- The effect of an inhaled leukotriene antagonist, L-648,051, on early and late asthmatic reactions and subsequent increase in airway responsiveness in manJournal of Allergy and Clinical Immunology, 1990
- Inhibition of Leukotriene D4-induced Bronchoconstriction in Normal Subjects by the Oral LTD4Receptor Antagonist ICI 204,219American Review of Respiratory Disease, 1990
- The Preclinical Pharmacology of ICI 204,219: A Peptide Leukotriene AntagonistAmerican Review of Respiratory Disease, 1990
- Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human SkinJournal of Investigative Dermatology, 1983
- The effect of synthetic leukotrienes on tracheal microvascular permeabilityProstaglandins, 1983
- SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS ANTAGONIST FPL 55712 IN CHRONIC ASTHMAThe Lancet, 1981
- Leukotrienes are potent constrictors of human bronchiNature, 1980